[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Analgesics in Costa Rica

November 2020 | 26 pages | ID: ABF9647F06CEN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
COVID-19’s impact on sales of analgesics was mostly felt during the first six to eight weeks following the initial lockdown measures that were announced and implemented by local health authorities on 18 March. Overall security perception, including the need to keep a required supply of these products at home, incentivized more planned shopping trips and resulted in stockpiling of certain types of analgesics. During this time, significant increases in demand were noticed for more affordable and b...

Euromonitor International's Analgesics in Costa Rica report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
KEY DATA FINDINGS
2020 IMPACT
Consumers begin to stockpile certain types of analgesics at the onset of lockdown in 2020, resulting in a temporary shortage
Sales begin to normalise in the second half of 2020 while major players turn to online marketing efforts to boost demand
International manufacturers lead in 2020 thanks to strong manufacturing capabilities and growing brand name recognition
RECOVERY AND OPPORTUNITIES
Availability and affordable pricing will continue to set the pace
Opportunity for development of private label at chained retailers
Combination products set to gain momentum due to increasing demand for targeted formulas
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources


More Publications